Brenig

Brenig is a small molecule drug development company that utilizes an AI/ML approach via a partnership with Expert Systems Inc., a drug accelerator that has spawned multiple best-in-class clinical candidates across multiple therapeutic areas.

Sectors
Healthcare
Life Sciences
First Invested
2024
Early
Company Status
Private
Board Members
Edward Mathers
Associated Team
J.C. Lopez, MD